GUIDO, MAURIZIO
 Distribuzione geografica
Continente #
NA - Nord America 3.643
AS - Asia 1.832
EU - Europa 1.428
SA - Sud America 412
AF - Africa 33
OC - Oceania 3
Totale 7.351
Nazione #
US - Stati Uniti d'America 3.566
SG - Singapore 1.171
IE - Irlanda 575
BR - Brasile 358
HK - Hong Kong 260
RU - Federazione Russa 260
CN - Cina 202
DE - Germania 169
IT - Italia 116
GB - Regno Unito 59
FI - Finlandia 55
CA - Canada 42
IN - India 36
SE - Svezia 28
CZ - Repubblica Ceca 26
JP - Giappone 26
VN - Vietnam 26
PL - Polonia 24
AR - Argentina 22
MX - Messico 20
BD - Bangladesh 19
BE - Belgio 19
FR - Francia 19
IQ - Iraq 16
NL - Olanda 16
ES - Italia 12
ZA - Sudafrica 11
AT - Austria 10
EC - Ecuador 10
KR - Corea 10
TR - Turchia 10
AE - Emirati Arabi Uniti 7
VE - Venezuela 7
ID - Indonesia 6
LT - Lituania 6
BG - Bulgaria 5
OM - Oman 5
SA - Arabia Saudita 5
UY - Uruguay 5
AL - Albania 4
AZ - Azerbaigian 4
CL - Cile 4
EE - Estonia 4
EG - Egitto 4
IL - Israele 4
NP - Nepal 4
TN - Tunisia 4
AU - Australia 3
CO - Colombia 3
JM - Giamaica 3
KG - Kirghizistan 3
KZ - Kazakistan 3
MA - Marocco 3
PK - Pakistan 3
RO - Romania 3
RS - Serbia 3
TW - Taiwan 3
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
HN - Honduras 2
IR - Iran 2
NO - Norvegia 2
UA - Ucraina 2
UZ - Uzbekistan 2
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
ET - Etiopia 1
GA - Gabon 1
GL - Groenlandia 1
GM - Gambi 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
KE - Kenya 1
LB - Libano 1
LU - Lussemburgo 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
MW - Malawi 1
NG - Nigeria 1
NI - Nicaragua 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
PY - Paraguay 1
QA - Qatar 1
SI - Slovenia 1
SN - Senegal 1
TG - Togo 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
Totale 7.351
Città #
Dallas 699
Singapore 596
Dublin 567
Chandler 556
Hong Kong 259
Santa Clara 254
Ashburn 174
Jacksonville 140
Boardman 132
New York 107
Los Angeles 92
The Dalles 89
Lawrence 82
Princeton 82
Wilmington 81
Des Moines 70
Columbus 66
Munich 66
Moscow 60
Falkenstein 57
San Mateo 47
Ann Arbor 37
Falls Church 34
Beijing 33
São Paulo 28
Tokyo 26
Helsinki 24
Rome 23
Warsaw 23
Brno 19
Brussels 19
Turku 17
L’Aquila 16
Poplar 15
Toronto 15
Montreal 14
Stockholm 14
Atlanta 13
Council Bluffs 13
Denver 13
Frankfurt am Main 13
Hefei 13
Lappeenranta 12
Mumbai 12
Norwalk 12
Brasília 11
Seoul 10
Shanghai 10
Amsterdam 9
Assago 9
Bremen 9
Chicago 9
Orem 9
San Francisco 9
Belo Horizonte 8
Boston 8
Brooklyn 8
Chennai 8
Curitiba 8
London 8
Ravenna 8
Baghdad 7
Düsseldorf 7
Hanover 7
Ho Chi Minh City 7
Johannesburg 7
Manchester 7
Rio de Janeiro 7
Seattle 7
Gioiosa Ionica 6
Jakarta 6
Lauterbourg 6
Phoenix 6
Ankara 5
Bristol 5
Charlotte 5
Houston 5
Mexico City 5
Montevideo 5
Olomouc 5
Pune 5
Sofia 5
Vienna 5
Baku 4
Betim 4
Campinas 4
Erbil 4
Guayaquil 4
Hanoi 4
Milan 4
Pittsburgh 4
Salvador 4
St Louis 4
Tappahannock 4
Barbacena 3
Berlin 3
Birmingham 3
Bishkek 3
Buffalo 3
Caxias do Sul 3
Totale 5.067
Nome #
Case report: incomplete Cauda Equina Syndrome following a caesarean section with spinal anaesthesia 113
"Evaluation of extracellular vesicle-associated TGF-β as a biomarker in patients with endometriosis" in Meeting abstracts of the 3° EVIta symposium 110
Sex ratio at birth: causes of variation and narrative review of literature 109
Acute insulin response to intravenous glucagon in polycystic ovary syndrome 108
Perinatal mental illness and autoimmune diseases: a qualitative sistematic review 108
Investigating Unhealthy Behaviors Associated with SF-36 Domains in Women with Endometriosis—Findings from a Web-Based Survey Data Set 104
A first stage placental site trophoblastic tumor: a case report and review of literature 103
Haemorrhoidal disease in pregnancy: results from a self-assessment questionnaire administered by means of a social network 103
Factors associated with chronic pelvic pain in women with endometriosis: A national study on clinical and sociodemographic characteristics, lifestyles, quality of life, and perceptions of quality of care, during the COVID-19 pandemic 101
The Impact of Metal Nanoparticles on Female Reproductive System: Risks and Opportunities 100
Effect of gonadotropin-releasing hormone agonist treatment on growth hormone responses in women with polycystic ovary syndrome 98
AGEs-related dysfunctions in PCOS: evidence from animal and clinical research 98
Differential androgen response to adrenocorticotropic hormone stimulation in polycystic ovarian syndrome: Relationship with insulin secretion 92
Sonographic features of pelvic tuberculosis mimicking ovarian-tubal-peritoneal carcinoma 90
Carbon dioxide in office diagnostic hysteroscopy: An open question. A multicenter randomized trial on 1982 procedures 90
Botulinum toxin in incontinent women with neurogenic bladder after failure with anticholinergic therapy, long-term results: a pilot study 89
Synchronous ovarian and uterine tumours, case report of an unusual association 87
ROLE OF VOCAL DISTRACTION ANALGESIA ON PAIN MANAGEMENT IN THE OFFICE HYSTEROSCOPY PROCEDURE: A RANDOMIZED CONTROLLED STUDY 86
Recurrent Metastatic Pulmonary Synovial Sarcoma during Pregnancy: A Case Report and Literature Review 85
The Accuracy of Third-Trimester Ultrasound in Predicting Large for Gestational Age or Macrosomic Fetuses in Diabetic and Non-Diabetic Pregnant Women: A Systematic Review and Meta-Analysis 84
Role of opioid antagonists in the treatment of women with glucoregulation abnormalities 81
Pre-eclampsia: From Etiology and Molecular Mechanisms to Clinical Tools. A Review of the Literature 80
The metabolic status modulates the effect of metformin on the antimullerian hormone-androgens-insulin interplay in obese women with polycystic ovary syndrome 80
Effect of corticotropin-releasing factor on the pituitary-ovary axis in human luteal phase 78
Second stimulation in the same ovarian cycle: an option to fully-personalize the treatment in poor prognosis patients undergoing PGT-A 78
Risk Assessment Model for Complications in Minimally Invasive Hysterectomy: A Pilot Study 77
COVID-19 and ART: the view of the Italian Society of Fertility and Sterility and Reproductive Medicine 77
Late third trimester diagnosis of congenital giant hemangioma complicated by the Kasabach-Merritt phenomen: a case report and literature review 74
Asymptomatic postmenopausal endometrial thickening: a comparison between transvaginal ultrasound and hysteroscopy in the diagnosis of intracavitary uterine pathologies 73
A pilot study of the long-term effects of acipimox in polycystic ovarian syndrome 73
Sonographic characteristics of ovarian Leydig cell tumor 72
How should the best human embryo in vitro be? Current and future challenges for embryo selection 72
The accuracy of prenatal cell-free DNA screening for sex chromosome abnormalities: a systematic review and meta-analysis 72
Suppression and recovery of gonadotropin and steroid secretion by a gonadotropin-releasing hormone receptor antagonist in healthy women with normal ovulation versus women with polycystic ovary syndrome in the early follicular phase 72
Changes in luteinizing hormone and insulin secretion in polycystic ovarian syndrome 72
The Perception of the Quality of Professional Healthcare Assistance for the Management of Endometriosis: Findings from a National Survey in Italy 71
Ultrasound Features and Clinical Outcome of Patients with Ovarian Masses Diagnosed during Pregnancy: Experience of Single Gynecological Ultrasound Center 70
How metformin acts in PCOS pregnant women: Insights into insulin secretion and peripheral action at each trimester of gestation 70
Administration of exogenous ghrelin in obese patients with polycystic ovary syndrome: effects on plasma levels of growth hormone, glucose, and insulin 70
The effect of age on the ovarian response to gonadotropin and on pregnancy rate in polycystic ovary syndrome 69
Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 69
Influence of body mass on the hypothalamic-pituitary-adrenal-axis response to naloxone in patients with polycystic ovary syndrome 69
DTC chemotherapy regimen is associated with higher incidence of premature ovarian failure in women of reproductive age with breast cancer 68
Ethinylestradio-chlormadinone acetate combination for the treatment of hirsutism and hormonal alterations of normal-weight women with polycystic ovary syndrome: Evaluation of the metabolic impact 68
Evidence of a disturbance of the hypothalamic-pituitary-adrenal axis in polycystic ovary syndrome: Effect of naloxone 68
The resting metabolic rate in women with polycystic ovary syndrome and its relation to the hormonal milieu, insulin metabolism, and body fat distribution: a cohort study 67
Alteration of ghrelin-neuropeptide Y network in obese patients with polycystic ovary syndrome: Role of hyperinsulinism 67
Effect of metformin on the growth hormone response to growth hormone-releasing hormone in obese women with polycystic ovary syndrome 67
Opioid blockade effect on insulin β-cells secretory patterns in polycystic ovary syndrome. Oral glucose load versus intravenous glucagon bolus 67
Using a 16-french resectoscope as an alternative device in the treatment of uterine lesions: A randomized controlled trial 67
Conservative management of preterm premature rupture of membranes < 30 weeks of gestational age: Effectiveness of clinical guidelines implementation strategies 66
Erratum: Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin as a trigger of ovulation in polycystic ovarian disease gonadotropin hyperstimulated cycles (Fertility and Sterility (1994) 62 (35- 41)) 66
Is the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma? 66
Metformin vs myoinositol: which is better in obese polycystic ovary syndrome patients? A randomized controlled crossover study 64
Comparison of absorbable and permanent sutures for laparoscopic sacrocervicopexy: A randomized controlled trial 64
Endocrinology: Effect of opioid blockade on insulin metabolism in polycystic ovarian disease 64
Preconceptional and gestational evaluation of insulin secretion in patients with polycystic ovary syndrome 64
Involvement of ovarian steroids in the opioid-mediated reduction of insulin secretion in hyperinsulinemic patients with polycystic ovary syndrome 64
The Italian guidelines on non-invasive and invasive prenatal diagnosis: Executive summary of recommendations for practice the Italian Society for Obstetrics and Gynecology (SIGO) 63
Differentiation of spermatogenic cells during in-vitro culture of testicular biopsy samples from patients with obstructive azoospermia: Effect of recombinant follicle stimulating hormone 63
Assessment of insulin resistance in lean women with polycystic ovary syndrome 63
Metformin improves endothelial function in normoinsulinemic PCOS patients: A new prospective 63
Naltrexone effect on pulsatile GnRH therapy for ovulation induction in polycystic ovary syndrome: A pilot prospective study 63
Vaginal mesh exposure after laparoscopic sacrocervicopexy performed with permanent or absorbable sutures 63
Perimesencephalic Subarachnoid Hemorrhage in Pregnancy 63
Tertiary Cytoreduction for Isolated Lymphnode Recurrence (ILNR) Ovarian Cancer in a BRCA2 Mutated Patient: Our Experience and Prevalence of BRCA 1 or 2 Genes Mutational Status in ILNR 62
Is there a role for soy isoflavones in the therapeutic approach to polycystic ovary syndrome? Results from a pilot study 62
Role of opioid tone in the pathophysiology of hyperinsulinemia and insulin resistance in polycystic ovarian disease 61
Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin as a trigger of ovulation in polycystic ovarian disease gonadotropin hyperstimulated cycles 61
The Impact of Thyroid Function on Human Reproduction: A Comprehensive Mini-Review 60
Conservative Management and Ultrasound Follow-Up of Parasitic Myoma: Our Experience and Literature Review 60
Somatostatin treatment reduces the exaggerated response of adrenocorticotropin hormone and cortisol to corticotropin-releasing hormone in polycystic ovary syndrome 60
Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: A clinical, endocrinological, metabolic pilot study 60
Follicular loss in endoscopic surgery for ovarian endometriosis: Quantitative and qualitative observations 60
Metformin treatment does not affect total leptin levels and free leptin index in obese patients with polycystic ovary syndrome 59
Laparoscopic sacrocolpopexy versus pelvic organ prolapse suspension for surgical management of pelvic organ prolapse: a retrospective study 59
Giant rapidly involuting congenital haemangioma and Kasabach-Merritt phenomenon: A potentially underhanded trap 58
Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome 58
Clinical efficacy andmetabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: A randomized study 57
Hypothalamic-pituitary-adrenal axis sensitivity to opioids in women with polycystic ovary syndrome 57
Human spermatogenesis in vitro: Respective effects of follicle- stimulating hormone and testosterone on meiosis, spermiogenesis, and sertoli cell apoptosis 57
Metformin effects on ovarian ultrasound appearance and steroidogenic function in normal-weight normoinsulinemic women with polycystic ovary syndrome: A randomized double-blind placebocontrolled clinical trial 57
How to improve MRI accuracy in detecting deep infiltrating colorectal endometriosis: MRI findings vs. laparoscopy and histopathology 57
Impact of insulin and body mass index on metabolic and endocrine variables in polycystic ovary syndrome 57
Expectant management may reduce overtreatment in women affected by unexplained infertility confirmed by diagnostic laparoscopy 56
Evaluation of ovarian and adrenal sources of androgens in women with polycystic ovary syndrome: Dexamethasone and GnRH-agonist administration 55
The Role of Anti-Müllerian Hormone in the Characterization of the Different Polycystic Ovary Syndrome Phenotypes 55
Effect of pioglitazone treatment on the adrenal androgen response to corticotrophin in obese patients with polycystic ovary syndrome 55
Favorable conception and pregnancy involving a male patient affected by chronic myeloid leukemia while taking dasatinib 55
Fertility preservation methods in breast cancer 55
Longitudinal metabolic observation of metformin effects during pregnancy in hyperinsulinemic women with polycystic ovary syndrome: A case report 55
Position paper on prevention of surgical site infections in obstetric and gynecological surgery 55
The link between metabolic features and TSH levels in polycystic ovary syndrome is modulated by the body weight: An euglycaemic-hyperinsulinaemic clamp study 54
Hyperinsulinemia in PCOS. Possible role in the determination of the ovary response to gonadotrophins 54
Pioglitazone reduces the adrenal androgen response to corticotropin-releasing factor without changes in ACTH release in hyperinsulinemic women with polycystic ovary syndrome 54
Sexual Function following Laparoscopic versus Transvaginal Closure of the Vaginal Vault after Laparoscopic Hysterectomy: Secondary Analysis of a Randomized Trial by the Italian Society of Gynecological Endoscopy Using a Validated Questionnaire 54
Metaphase‑II oocyte competence is unlinked to the gonadotrophins used for ovarian stimulation: a matched case–control study in women of advanced maternal age 53
The use of different size-hysteroscope in office hysteroscopy: Our experience 53
Postmenarchal Down's syndrome: A theoretical model of growth hormone action on ovarian function 52
Nerve-Sparing Laparoscopic Colposacropexy Using a Percutaneous Surgical System: A Case Report 49
Totale 7.061
Categoria #
all - tutte 40.602
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.602


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021265 0 0 0 0 0 0 0 70 75 2 117 1
2021/2022425 0 4 3 9 32 35 9 32 41 32 37 191
2022/20231.675 122 116 35 162 78 194 27 126 699 11 83 22
2023/2024480 71 17 43 34 33 110 22 35 3 51 22 39
2024/20252.450 53 48 174 148 298 280 331 125 553 107 162 171
2025/20262.240 210 344 600 518 518 50 0 0 0 0 0 0
Totale 7.535